{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": "Derivative use for direct investment, not just efficient portfolio management; potential for counterparty risk; sub-investment grade (high yield) bond exposure; ESG/SRI screening may reduce liquidity; securities lending introduces additional counterparty risk",
    "classification": "non-complex",
    "supporting_data": "The ETF is a UCITS-compliant, physically replicated fund tracking a transparent, market-cap-weighted index of Euro-denominated, sub-investment grade corporate bonds with ESG/SRI screening. While UCITS ETFs are generally presumed non-complex under MiFID II Article 25(4)(a)(iv), this presumption can be overturned if the fund's structure, risks, or payoff are difficult for a retail investor with basic knowledge to understand. Here, the fund uses derivatives for direct investment purposes (not solely for efficient portfolio management), which introduces counterparty risku2014a factor that regulators often consider when assessing complexity. However, the fund's documentation does not indicate that derivatives are central to the strategy (e.g., no synthetic replication or embedded options), and the risks are clearly disclosed. The underlying index is transparent and the replication method is physical (optimized sampling), supporting non-complexity. Securities lending is present but within UCITS limits and with collateral, which does not automatically trigger complexity. The fund's high yield bond exposure and ESG/SRI screening may affect liquidity but do not, by themselves, make the structure opaque or hard to understand. Overall, while there are elements that could contribute to complexity (derivative use, counterparty risk, sub-investment grade bonds), the fund's structure, transparency, and regulatory framework support a non-complex classification under MiFID II, absent evidence that the derivative use is central or that the structure is otherwise opaque or difficult for a retail investor to understand[1][2]. If the derivative use were more integral (e.g., synthetic replication) or if the fund held complex structured products (e.g., CLOs), the classification would likely be complex, but this is not indicated here."
}